American Association for the study of liver disease
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
... other liver diseases in the United States ...The American Association for the Study of Liver Diseases (AASLD) practice guide 2018 [41] recommends that the risk of HCC is significantly ...
24
Nonalcoholic fatty liver disease and chronic kidney disease in patients with chronic heart failure
... Kidney Disease Epidemiology Collaboration), which takes into account race, sex, age, serum creatinine (Renal function and prediction of cardiovascular risk, ...be liver biopsy. The risk of complications and ...
6
Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology – a prospective study
... AASLD: American Association for the Study of Liver Diseases; AFP: alpha- fetoprotein; AJCC: American Joint Committee on Cancer; CECT: contrast enhanced computed tomogram; CTP: ...
5
HBV associated intrahepatic cholangiocarcinoma with high serum alpha fetoprotein: a case report with review of literature
... from disease recurrence, which high- lights the need for more effective systemic therapy ...case study, the patient received surgery and gemcitabine combined with platinum-based adjuvant chemotherapy, and ...
6
A cross-sectional study of chronic liver disease patients complicating to hepatic osteodystrophy
... chronic liver disease (CLD) ...and American gastroenterology ,very less number of literature exist from India and none from the North-eastern region of ...the study to determine the ...
6
Association of non-alcoholic fatty liver disease with chronic kidney disease in type 2 diabetes mellitus
... cross-sectional study conducted at Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India from February 2017 to March 2018, 268 diagnosed cases of type 2 diabetes mellitus (American Diabetes ...
5
Hepatitis C Testing Among Perinatally Exposed Infants
... Hepatitis C virus (HCV) is the most common blood-borne infection in the United States, affecting an estimated 2.4 million currently. 1 Reported new HCV infections are on the rise, especially in rural areas among young ...
11
Hepatitis C Testing Among Perinatally Exposed Infants
... Hepatitis C virus (HCV) is the most common blood-borne infection in the United States, affecting an estimated 2.4 million currently. 1 Reported new HCV infections are on the rise, especially in rural areas among young ...
11
Response of Sofosbuvir and Daclatasvir combination in Chronic Hepatitis C with Hemodialysis Pakistani Patients: A Single Centre Study
... per study results, the DAC- SOF combination was safe, well tolerated and highly effective (shown high SVR rates) for HD patients with genotype 3 HCV ...natural disease progression in these ...
9
The Care of Children With Congenital Heart Disease in Their Primary Medical Home
... the American Academy of Pediatrics (AAP) and the American College of Cardiology (ACC) assembled a team of experts, including representation from the AAP Committee on Practice and Ambulatory Medicine, to ...
12
Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study
... reactivation of HBV, transaminases were more than 10-fold of upper limit of the normal range (ULN), and HBV-DNA was > 20,000 IU/mL. In one case, reactivation occurred 8 months after the start of azathioprine admin- ...
8
Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence
... Abstract: Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious with fewer adverse events, due to the availability of direct-acting antiviral agents, which target specific steps in the ...
8
Prognostic models for alcoholic hepatitis
... retrospective study evaluating 9 different scoring systems, the sensitivity and specificity of the ABIC score for 30-day mortality were 100 % and 20 %, respectively, for a cut-off of ...for liver ...
8
Protocol of a prospective study for the combination treatment of Shu Gan jian Pi decoction and steroid standard therapy in autoimmune hepatitis patients
... this study is to evaluate the effects of Shu-Gan-Jian-Pi Decoction combined with steroid in AIH ...this study aims to explore whether the combination treatment of Shu-Gan-Jian-Pi Decoction and steroid ...
5
Identification of causative organisms and role of Ceftriaxone in Spontaneous Bacterial Peritonitis (SBP) secondary to Decompensated Liver Disease
... Even American society for study of liver disease (ASSLD) has recommended that every hospitalized patient with ascites should have diagnostic ascetic tap as 10 to 30 % of patients with ...
7
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East
... Cardiovascular disease (CVD) is a growing burden across the ...the American College of Cardiology/American Heart Association, which all have similarities in practice recommendations for the ...
10
Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US based cost effectiveness modeling study
... placebo-controlled study comparing the safety and efficacy of therapy with peginterferon alfa-2b and ribavirin (PegIntron and Rebetol, respectively; Merck) with two treat- ment regimens that added boceprevir ...
17
The association of sleep quality with dry eye disease: the Osaka study
... the association of DED parameters (the Schirmer test-I values, tear film break-up time [BUT] test values, corneal and conjunctival staining scores, and symptoms) with physical activity level and sleep ...this ...
7
Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial
... study arm as part of the intention-to-treat group (ITT). Patients who are eligible for RE will commence treatment between the second and fifth week after randomisation with a single session of treatment (the day ...
8
DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center
... non-randomized study where 21 patients with intermediate and advanced HCC, from a tertiary referral cancer center, were selected and submit- ted to DEB TACE loaded with doxorubicin from Sep- tember 2009 thru April ...
9